LBelEFFET PARFAIT (Ventura Corporation Ltd)
Welcome to the PulseAid listing for the LBel drug offered from Ventura Corporation Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ventura Corporation Ltd |
NON-PROPRIETARY NAME: | TITANIUM DIOXIDE, OXYBENZONE, and OCTINOXATE |
SUBSTANCE NAME: | TITANIUM DIOXIDE; OXYBENZONE; OCTINOXATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | POWDER |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2012-01-24 |
END MARKETING DATE: | 0000-00-00 |
LBel EFFET PARFAIT HUMAN OTC DRUG Details:
Item Description | LBel EFFET PARFAIT from Ventura Corporation Ltd |
LABELER NAME: | Ventura Corporation Ltd |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .04425; .03; .04(g/g; g/g; g/g) |
START MARKETING DATE: | 2012-01-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13537-148_92954fd7-301b-4075-8764-25a8430fe7dc |
PRODUCT NDC: | 13537-148 |
APPLICATION NUMBER: | part352 |
Other TITANIUM DIOXIDE; OXYBENZONE; OCTINOXATE Pharmaceutical Manufacturers / Labelers: